Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

Xin Jin, Donglin Ding, Yuqian Yan, Hui Li, Bo Wang, Linlin Ma, Zhenqing Ye, Tao Ma, Qiang Wu, Daniel N. Rodrigues, Manish Kohli, Rafael E Jimenez, Liguo Wang, David W. Goodrich, Johann de Bono, Haidong M Dong, Heshui Wu, Runzhi Zhu, Haojie Huang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

RB is known to act as a tumor suppressor by inhibiting E2F transcription factors, and this function is abolished due to its phosphorylation by CDKs. Jin et al. identify a previously uncharacterized tumor suppressor role of CDK4/6-phosphorylated RB in promoting cancer immunity via inhibition of NF-κB transcriptional activity and PD-L1 expression.

Original languageEnglish (US)
Pages (from-to)22-35.e6
JournalMolecular Cell
Volume73
Issue number1
DOIs
StatePublished - Jan 3 2019

Fingerprint

Immunity
E2F Transcription Factors
Neoplasms
Phosphorylation

Keywords

  • CDK4/6 inhibitor
  • CHD1
  • immunotherapy
  • MAP3K7
  • NF-κB
  • PD-L1
  • phosphorylation
  • prostate cancer
  • radiotherapy
  • RB

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression. / Jin, Xin; Ding, Donglin; Yan, Yuqian; Li, Hui; Wang, Bo; Ma, Linlin; Ye, Zhenqing; Ma, Tao; Wu, Qiang; Rodrigues, Daniel N.; Kohli, Manish; Jimenez, Rafael E; Wang, Liguo; Goodrich, David W.; de Bono, Johann; Dong, Haidong M; Wu, Heshui; Zhu, Runzhi; Huang, Haojie.

In: Molecular Cell, Vol. 73, No. 1, 03.01.2019, p. 22-35.e6.

Research output: Contribution to journalArticle

Jin, X, Ding, D, Yan, Y, Li, H, Wang, B, Ma, L, Ye, Z, Ma, T, Wu, Q, Rodrigues, DN, Kohli, M, Jimenez, RE, Wang, L, Goodrich, DW, de Bono, J, Dong, HM, Wu, H, Zhu, R & Huang, H 2019, 'Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression', Molecular Cell, vol. 73, no. 1, pp. 22-35.e6. https://doi.org/10.1016/j.molcel.2018.10.034
Jin, Xin ; Ding, Donglin ; Yan, Yuqian ; Li, Hui ; Wang, Bo ; Ma, Linlin ; Ye, Zhenqing ; Ma, Tao ; Wu, Qiang ; Rodrigues, Daniel N. ; Kohli, Manish ; Jimenez, Rafael E ; Wang, Liguo ; Goodrich, David W. ; de Bono, Johann ; Dong, Haidong M ; Wu, Heshui ; Zhu, Runzhi ; Huang, Haojie. / Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression. In: Molecular Cell. 2019 ; Vol. 73, No. 1. pp. 22-35.e6.
@article{b897325137384af284e1c07dd5df194d,
title = "Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression",
abstract = "RB is known to act as a tumor suppressor by inhibiting E2F transcription factors, and this function is abolished due to its phosphorylation by CDKs. Jin et al. identify a previously uncharacterized tumor suppressor role of CDK4/6-phosphorylated RB in promoting cancer immunity via inhibition of NF-κB transcriptional activity and PD-L1 expression.",
keywords = "CDK4/6 inhibitor, CHD1, immunotherapy, MAP3K7, NF-κB, PD-L1, phosphorylation, prostate cancer, radiotherapy, RB",
author = "Xin Jin and Donglin Ding and Yuqian Yan and Hui Li and Bo Wang and Linlin Ma and Zhenqing Ye and Tao Ma and Qiang Wu and Rodrigues, {Daniel N.} and Manish Kohli and Jimenez, {Rafael E} and Liguo Wang and Goodrich, {David W.} and {de Bono}, Johann and Dong, {Haidong M} and Heshui Wu and Runzhi Zhu and Haojie Huang",
year = "2019",
month = "1",
day = "3",
doi = "10.1016/j.molcel.2018.10.034",
language = "English (US)",
volume = "73",
pages = "22--35.e6",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Phosphorylated RB Promotes Cancer Immunity by Inhibiting NF-κB Activation and PD-L1 Expression

AU - Jin, Xin

AU - Ding, Donglin

AU - Yan, Yuqian

AU - Li, Hui

AU - Wang, Bo

AU - Ma, Linlin

AU - Ye, Zhenqing

AU - Ma, Tao

AU - Wu, Qiang

AU - Rodrigues, Daniel N.

AU - Kohli, Manish

AU - Jimenez, Rafael E

AU - Wang, Liguo

AU - Goodrich, David W.

AU - de Bono, Johann

AU - Dong, Haidong M

AU - Wu, Heshui

AU - Zhu, Runzhi

AU - Huang, Haojie

PY - 2019/1/3

Y1 - 2019/1/3

N2 - RB is known to act as a tumor suppressor by inhibiting E2F transcription factors, and this function is abolished due to its phosphorylation by CDKs. Jin et al. identify a previously uncharacterized tumor suppressor role of CDK4/6-phosphorylated RB in promoting cancer immunity via inhibition of NF-κB transcriptional activity and PD-L1 expression.

AB - RB is known to act as a tumor suppressor by inhibiting E2F transcription factors, and this function is abolished due to its phosphorylation by CDKs. Jin et al. identify a previously uncharacterized tumor suppressor role of CDK4/6-phosphorylated RB in promoting cancer immunity via inhibition of NF-κB transcriptional activity and PD-L1 expression.

KW - CDK4/6 inhibitor

KW - CHD1

KW - immunotherapy

KW - MAP3K7

KW - NF-κB

KW - PD-L1

KW - phosphorylation

KW - prostate cancer

KW - radiotherapy

KW - RB

UR - http://www.scopus.com/inward/record.url?scp=85059121899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059121899&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2018.10.034

DO - 10.1016/j.molcel.2018.10.034

M3 - Article

VL - 73

SP - 22-35.e6

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 1

ER -